William Traverse

Behcet's-like syndrome following pembrolizumab: An immune-related adverse event associated with programmed death receptor-1 inhibitor therapy

Case report · Journal of Oncology Pharmacy Practice · 2020 · Last of 4 authors · 9 citations

Neuroendocrine manifestations of phospholipid antibody disease identified by long-term follow-up study of patients with phospholipid antibodies

Annals of the New York Academy of Sciences · 2006 · First of 5 authors · 2 citations